Buscar
Mostrando ítems 1-10 de 10
HTLV-1 infection in solid organ transplant donors and recipients in Spain
(BMC Invectious Diseases, 2019-08-09)
Background: HTLV-1 infection is a neglected disease, despite infecting 10-15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated ...
Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain
(Open Forum Infectious Diseases, 2019-02)
Background. Although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late ...
Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains
(Emerging Microbes and Infections, 2020-01-01)
Africa is the largest endemic area for HTLV-1, with many molecular genotypes. We previously demonstrated that some strains from North Africa (a-NA clade) originated from a recombinant event between Senegalese and West ...
Situación epidemiológica actual de la infección por VIH-2 y HTLV-1 en España
(2021)
La familia Retroviridae incluye 7 subfamilias. Los miembros de
2 de ellas infectan a humanos y son patogénicos. Se trata de los
deltarretrovirus, de los cuales el human T-cell lymphotropic virus
(HTLV, «virus linfotrópico ...
Situación epidemiológica actual de la infección por VIH-2 y HTLV-1 en España
(Medicina clinica, 2021)
La familia Retroviridae incluye 7 subfamilias. Los miembros de
2 de ellas infectan a humanos y son patogénicos. Se trata de los
deltarretrovirus, de los cuales el human T-cell lymphotropic virus
(HTLV, «virus linfotrópico ...
Consideraciones sobre la infección por HTLV-1 en España
(Medicina clinica, 2021)
Consideraciones sobre la infección por HTLV-1 en España.
Pre-Exposure Prophylaxis for viral infections other than HIV
(Infezioni in Medicina, 2022)
The battle against human viral infections has histori-cally relied on two medical strategies, namely vaccines to protect from contagion and antivirals to treat infected patients. In the absence of vaccines, antivirals have ...
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
(International Journal of Infectious Diseases, 2022)
Objectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently ...
Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals
(Therapeutic Advances in Infectious Disease, 2019-08)
Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral ...
The slowdown of new infections by human retroviruses has reached a plateau in Spain
(Journal of Medical Virology, 2023)
The 2022 annual meeting of the HTLV & HIV-2 Spanish Network was held in Madrid on December 14. We summarize here the main information presented and discussed at the workshop and review time trends for human retroviral ...